Design and rationale of the EMPA‐VISION trial: investigating the metabolic effects of empagliflozin in patients with heart failure.
- Resource Type
- Article
- Source
- ESC Heart Failure; Aug2021, Vol. 8 Issue 4, p2580-2590, 11p
- Subject
EMPAGLIFLOZIN HEART failure treatment ENERGY metabolism - Language
- ISSN
- 20555822